These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
210 related items for PubMed ID: 8029796
1. Inhibition of in vitro clot growth by r-hirudin is more effective and longer sustained than by an analogous peptide. Römisch J, Stöhr HA, Stauss H, Koschinsky R, Stüber W, Pâques EP. Thromb Haemost; 1994 Mar; 71(3):320-4. PubMed ID: 8029796 [Abstract] [Full Text] [Related]
2. The effect of antithrombin III-independent thrombin inhibitors and heparin on fibrin accretion onto fibrin-coated polyethylene. Rubens FD, Weitz JI, Brash JL, Kinlough-Rathbone RL. Thromb Haemost; 1993 Feb 01; 69(2):130-4. PubMed ID: 8456425 [Abstract] [Full Text] [Related]
3. Inhibition of thrombin by synthetic hirudin peptides. Binnie CG, Erickson BW, Hermans J. FEBS Lett; 1990 Sep 17; 270(1-2):85-9. PubMed ID: 2226793 [Abstract] [Full Text] [Related]
4. Clot-bound thrombin is protected from inhibition by heparin-antithrombin III but is susceptible to inactivation by antithrombin III-independent inhibitors. Weitz JI, Hudoba M, Massel D, Maraganore J, Hirsh J. J Clin Invest; 1990 Aug 17; 86(2):385-91. PubMed ID: 2384594 [Abstract] [Full Text] [Related]
5. Fibrin-targeted recombinant hirudin inhibits fibrin deposition on experimental clots more efficiently than recombinant hirudin. Bode C, Hudelmayer M, Mehwald P, Bauer S, Freitag M, von Hodenberg E, Newell JB, Kübler W, Haber E, Runge MS. Circulation; 1994 Oct 17; 90(4):1956-63. PubMed ID: 7923685 [Abstract] [Full Text] [Related]
8. Laboratory assays for the evaluation of recombinant hirudin. Walenga JM, Hoppensteadt D, Koza M, Wallock M, Pifarre R, Fareed J. Haemostasis; 1991 Oct 17; 21 Suppl 1():49-63. PubMed ID: 1894197 [Abstract] [Full Text] [Related]
9. Effects of the synthetic thrombin inhibitor argatroban on fibrin- or clot-incorporated thrombin: comparison with heparin and recombinant Hirudin. Berry CN, Girardot C, Lecoffre C, Lunven C. Thromb Haemost; 1994 Sep 17; 72(3):381-6. PubMed ID: 7855788 [Abstract] [Full Text] [Related]
10. Inhibition of the amplification reactions of blood coagulation by site-specific inhibitors of alpha-thrombin. Ofosu FA, Fenton JW, Maraganore J, Blajchman MA, Yang X, Smith L, Anvari N, Buchanan MR, Hirsh J. Biochem J; 1992 May 01; 283 ( Pt 3)(Pt 3):893-7. PubMed ID: 1590777 [Abstract] [Full Text] [Related]
11. Production, properties, and thrombin inhibitory mechanism of hirudin amino-terminal core fragments. Chang JY. J Biol Chem; 1990 Dec 25; 265(36):22159-66. PubMed ID: 2266119 [Abstract] [Full Text] [Related]
15. Displacement of fibrin-bound thrombin by r-hirudin precludes the use of 131I-r-hirudin for detecting pulmonary emboli in the rabbit. Rubens FD, Ross-Ouellet B, Dennie C, Coates G, Kinlough-Rathbone RL, Hatton MW. Thromb Haemost; 1994 Aug 25; 72(2):232-8. PubMed ID: 7831658 [Abstract] [Full Text] [Related]
16. Effect of the hirudin carboxy-terminal peptide 54-65 on the interaction of thrombin with platelets. Jandrot-Perrus M, Huisse MG, Krstenansky JL, Bezeaud A, Guillin MC. Thromb Haemost; 1991 Sep 02; 66(3):300-5. PubMed ID: 1746000 [Abstract] [Full Text] [Related]
18. Rational design of true hirudin mimetics: synthesis and characterization of multisite-directed alpha-thrombin inhibitors. Lombardi A, Nastri F, Della Morte R, Rossi A, De Rosa A, Staiano N, Pedone C, Pavone V. J Med Chem; 1996 May 10; 39(10):2008-17. PubMed ID: 8642559 [Abstract] [Full Text] [Related]